Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1

Therapeutics and Clinical Risk Management

ISSN: 1178-203X


Archive: Volume 3, 2007


Acne phototherapy with a 1450-nm diode laser: an open study

Natusko Konishi, Hideki Endo, Naoki Oiso, Shigeru Kawara, Akira Kawada

Therapeutics and Clinical Risk Management 2007, 3:205-209

Published Date: 15 March 2007

Polypharmacy in elderly patients at discharge from the acute care hospital

Andrea Corsonello, Claudio Pedone, Francesco Corica, Raffaele Antonelli Incalzi, On behalf of the Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) investigators

Therapeutics and Clinical Risk Management 2007, 3:197-203

Published Date: 15 March 2007

Hypokalemia secondary to capecitabine: a hidden toxicity?

Muhammad Wasif Saif, Mohammad Houman Fekrazad, Leslie Ledbetter, Robert B Diasio

Therapeutics and Clinical Risk Management 2007, 3:177-180

Published Date: 15 March 2007

Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia

R Lozano, MG Peralta Concha, A Montealegre, L de Leon, J Ortiz Villalba, et al

Therapeutics and Clinical Risk Management 2007, 3:149-155

Published Date: 15 March 2007

Adalimumab in the treatment of arthritis

Philip J Mease

Therapeutics and Clinical Risk Management 2007, 3:133-148

Published Date: 15 March 2007

Optimal timing for antihypertensive dosing: focus on valsartan

Ramón C Hermida, Diana E Ayala, Carlos Calvo

Therapeutics and Clinical Risk Management 2007, 3:119-131

Published Date: 15 March 2007

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom

Peter Layer, Jutta Keller, Helena Loeffler, Andreas Kreiss

Therapeutics and Clinical Risk Management 2007, 3:107-118

Published Date: 15 March 2007

Etanercept in the treatment of rheumatoid arthritis

Boulos Haraoui, Vivian Bykerk

Therapeutics and Clinical Risk Management 2007, 3:99-105

Published Date: 15 March 2007

Comparison of echinocandin antifungals

Gregory Eschenauer, Daryl D DePestel, Peggy L Carver

Therapeutics and Clinical Risk Management 2007, 3:71-97

Published Date: 15 March 2007

Venlafaxine extended release (XR) in the treatment of panic disorder

Kevin Kjernisted, Diane McIntosh

Therapeutics and Clinical Risk Management 2007, 3:59-69

Published Date: 15 March 2007

Drug management in chronic rhinosinusitis: identification of the needs

Jean-Baptiste HPJ Watelet, Philippe H Eloy, Paul B van Cauwenberge

Therapeutics and Clinical Risk Management 2007, 3:47-57

Published Date: 15 March 2007

Drug reimportation practices in the United States

Monali J Bhosle, Rajesh Balkrishnan

Therapeutics and Clinical Risk Management 2007, 3:41-46

Published Date: 15 March 2007

Therapy of autoimmune bullous diseases

Diya F Mutasim

Therapeutics and Clinical Risk Management 2007, 3:29-40

Published Date: 15 March 2007

Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study

Gian Luigi Marseglia, Mariangela Tosca, Ignazio Cirillo, Amelia Licari, Maddalena Leone, Alessia Marseglia, Anna Maria Castellazzi, Giorgio Ciprandi

Therapeutics and Clinical Risk Management 2007, 3:13-17

Published Date: 15 March 2007

The use of amisulpride in the treatment of acute psychosis

Philippe Nuss, Martina Hummer, Cédric Tessier

Therapeutics and Clinical Risk Management 2007, 3:3-11

Published Date: 15 March 2007

Editorial ||FREE PAPER||

Garry M Walsh

Therapeutics and Clinical Risk Management 2007, 3:1-2

Published Date: 15 March 2007